Search Results - "Merkesdal, Sonja"

Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma by Dettmer, Arne, Kirchhoff, Timm-D, Gebel, Michael, Zender, Lars, Malek, Nisar-P, Panning, Bernhard, Chavan, Ajay, Rosenthal, Herbert, Kubicka, Stefan, Krusche, Susanne, Merkesdal, Sonja, Galanski, Michael, Manns, Michael-P, Bleck, Joerg-S

“…AIM： To evaluate the treatment effect of percutaneous ethanol injection （PEI） for patients with advanced, non-resectable HCC compared with combination of…”
Get full text

Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival by Kirchhoff, Timm D, Bleck, Joerg S, Dettmer, Arne, Chavan, Ajay, Rosenthal, Herbert, Merkesdal, Sonja, Frericks, Bernd, Zender, Lars, Malek, Nisar P, Greten, Tim F, Kubicka, Stefan, Manns, Michael P, Galanski, Michael

“…BACKGROUND: In a multidisciplinary conference patients with advanced non-resectable hepatocellular carcinoma (HCC) were stratified according to their clinical…”
Get full text

Initial experience from a combination of systemic and regional chemotherapy in the treatment of patients with nonresectable cholangiocellular carcinoma in the liver by Kirchhoff, Timm, Zender, Lars, Merkesdal, Sonja, Frericks, Bernd, Malek, Nisar, Bleck, Joerg, Kubicka, Stefan, Baus, Stefan, Chavan, Ajay, Manns, Michael-P, Galanski, Michael

“…AIM: In nonresectable cholangiocellular carcinoma (CCC) therapeutic options are limited. Recently, systemic chemotherapy has shown response rates of up to 30%…”
Get full text

Public Health Relevance of Graves' Orbitopathy by Ponto, Katharina A, Merkesdal, Sonja, Hommel, Gerhard, Pitz, Susanne, Pfeiffer, Norbert, Kahaly, George J

“…Context: Disfiguring proptosis and functional impairment in patients with Graves' orbitopathy (GO) may lead to impaired earning capacity and to considerable…”
Get full text

Intraindividual Comparisons to Determine Comparative Effectiveness: Their Relevance for G-BA’s Health Technology Assessments by Wagle, Julia Annabel, Flacke, Jan-Paul, Knoerzer, Dietrich, Ruof, Jörg, Merkesdal, Sonja

“…Health technology assessments (HTA) rely on head-to-head comparisons. We searched for intraindividual comparisons (IIC) qualifying as head-to-head design to…”
Get full text

Patients With Arthralgia and Anti–Citrullinated Peptide Antibody Positivity on Hydroxychloroquine Therapy: An Update on 2 and 3 Yearsʼ Follow-up Data of a Pilot Study by Merkesdal, Sonja, Kirchhoff, Timm, Jablonka, Alexandra, Schmidt, Reinhold E, Köhler, Lars

Get full text

Type I Diabetes is the Main Cost Driver in Autoimmune Polyendocrinopathy by Radermacher, Lena-Katharina, Ponto, Katharina, Merkesdal, Sonja, Pomart, Vanessa, Frommer, Lara, Pfeiffer, Norbert, König, J, Kahaly, George J

“…Abstract Context Autoimmune polyendocrinopathy (AP), a chronic complex orphan disease, encompasses at least two autoimmune-induced endocrine diseases…”
Get full text

Pregnancy Related Health Care Needs in Refugees-A Current Three Center Experience in Europe by Dopfer, Christian, Vakilzadeh, Annabelle, Happle, Christine, Kleinert, Evelyn, Müller, Frank, Ernst, Diana, Schmidt, Reinhold E, Behrens, Georg M N, Merkesdal, Sonja, Wetzke, Martin, Jablonka, Alexandra

“…Immigration into Europe has reached an all-time high. Provision of coordinated healthcare, especially to refugee women that are at increased risk for adverse…”
Get full text

Patients With Arthralgia and Anti–Citrullinated Peptide Antibody Positivity on Hydroxychloroquine Therapy: An Update on 2 and 3 Yearsʼ Follow-up Data of a Pilot Study by Merkesdal, Sonja, Kirchhoff, Timm, Jablonka, Alexandra, Schmidt, Reinhold E., Köhler, Lars

Get full text

Instruments for Measuring the Effects of Early Intervention on Maintaining and Restoring Ability to Work in Germany: Opinion of an Interdisciplinary Working Group by Amler, N, Felder, S, Mau, W, Merkesdal, S, Schöffski, O

“…In projects on early intervention, a wide variety of instruments is used for the measurement of intervention effects on preservation or restoration of ability…”
Get more information

Measles, Rubella and Varicella IgG Seroprevalence in a Large Refugee Cohort in Germany in 2015: A Cross-Sectional Study by Jablonka, Alexandra, Happle, Christine, Wetzke, Martin, Dopfer, Christian, Merkesdal, Sonja, Schmidt, Reinhold E., Behrens, Georg M. N., Solbach, Philipp

“…Introduction The current extent of migration to the European continent is associated with exceptional humanitarian challenges. In 2015, Western Europe faced an…”
Get full text

German Recommendations on Health Economic Evaluation: Third and Updated Version of the Hanover Consensus by von der Schulenburg, J.-Matthias Graf, PhD, Greiner, Wolfgang, PhD, Jost, Fred, MSc, Klusen, Norbert, PhD, Kubin, Maria, MD, Leidl, Reiner, PhD, Mittendorf, Thomas, PhD, Rebscher, Herbert, PhD, Schoeffski, Oliver, PhD, Vauth, Christoph, MSc, Volmer, Timm, DVM, MPH, Wahler, Steffen, MD, Wasem, Juergen, PhD, Weber, Christian, MD

“…Financial restrictions and a stronger focus on outcomes assessment require rational decision regarding the allocation of resources in the health care system…”
Get full text

Cost-effectiveness analysis of rituximab treatment in patients in Germany with rheumatoid arthritis after etanercept-failure by Merkesdal, Sonja, Kirchhoff, Timm, Wolka, Diane, Ladinek, Gunter, Kielhorn, Adrian, Rubbert-Roth, Andrea

“…Objective The present health economic analysis investigated the cost-effectiveness-ratios of either (1) rituximab or (2) an alternative TNF-alpha-inhibiting…”
Get full text

Cost of illness in rheumatoid arthritis in Germany in 1997―98 and 2002: cost drivers and cost savings by KIRCHHOFF, Timm, RUOF, Jörg, MITTENDORF, Thomas, RIHL, Markus, BERNATECK, Michael, MAU, Wilfried, ZEIDLER, Henning, SCHMIDT, Reinhold E, MERKESDAL, Sonja

“…Comparison of overall RA-related costs and of relative contribution of single-cost domains before and after the introduction of TNF-blocking agents in Germany…”
Get full text

Cost-effectiveness simulation model of biologic strategies for treating to target rheumatoid arthritis in Germany by Beresniak, Ariel, Baerwald, Christoph, Zeidler, Henning, Krüger, Klaus, Neubauer, Aljoscha S, Dupont, Danielle, Merkesdal, Sonja

“…The treatment of active rheumatoid arthritis (RA) usually requires different therapeutic options used sequentially in case of an insufficient response (IR) to…”
Get full text

TNF-blocking therapy in rheumatoid arthritis and ankylosing spondylitis: why is cost-effectiveness a major issue? by Merkesdal, Sonja, Zeidler, Henning

Get full text

Interest of modelling in rheumatoid arthritis by Beresniak, Ariel, Dupont, Danielle M, Becker, Jean-Claude, Merkesdal, Sonja

“…Such as prospective studies can provide evidence-based information for clinicians and regulatory agencies, modelling studies provide useful information when…”
Get full text

Cost-effectiveness of TNF-α inhibition in active ankylosing spondylitis: a systematic appraisal of the literature by Kirchhoff, Timm D, Mittendorf, Thomas, Schmidt, Reinhold E, Jablonka, Alexandra, Merkesdal, Sonja

“…Ankylosing spondylitis (AS) is the most frequent prototype of spondyloarthritides. Substantial direct costs and productivity losses often arise in young…”
Get more information

Sustained effects of comprehensive inpatient rehabilitative treatment and sleeping neck support in patients with chronic cervicobrachialgia: a prospective and randomized clinical trial by Bernateck, Michael, Karst, Matthias, Merkesdal, Sonja, Fischer, Michael J, Gutenbrunner, Christoph

“…The objective of this study was to investigate the long-term efficacy of inpatient rehabilitation using sleeping neck support in patients suffering from…”
Get full text

Prediction of costs-of-illness in patients with low back pain undergoing orthopedic outpatient rehabilitation by Merkesdal, Sonja, Mau, Wilfried

“…The objectives of this study were (1) to assess societal costs-of-illness and their changes in the year prior to and after outpatient rehabilitation (OPR) in…”
Get full text